SCHEMBL23488258

SCHEMBL23488258

NC(=O)c1ccc(OC(=O)c2ccccc2)nc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NNMT P40261 3/20 0.58
PARP10 Q53GL7 1/20 0.58
OPRM1 P35372 8/20 0.52
OPRK1 P41145 7/20 0.52
OPRD1 P41143 7/20 0.52
SMN1; SMN2 Q16637 1/20 0.51
KCNH2 Q12809 2/20 0.49
GRIN2D O15399 1/20 0.49
GRIN3B O60391 1/20 0.49
SLC6A2 P23975 1/20 0.49
SLC6A3 Q01959 1/20 0.49
GRIN1 Q05586 1/20 0.49
GRIN2A Q12879 1/20 0.49
GRIN2B Q13224 1/20 0.49
ROCK1 Q13464 1/20 0.49
GRIN2C Q14957 1/20 0.49
GRIN3A Q8TCU5 1/20 0.49
GRM5 P41594 1/20 0.48
MAPT P10636 2/20 0.47
POLB P06746 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23486304 0.87 MAPT (0.56) PARP10SMN1; SMN2MAPTTSHRCYP2C19
SCHEMBL23488402 0.85 F7 (0.63) NNMTSMN1; SMN2MAPTTSHRCYP2C19
SCHEMBL22557648 0.82 KMT2A (0.47) PARP10SMN1; SMN2GRM5MAPTPOLB
SCHEMBL31426894 0.80 KMT2A (0.53) PARP10SMN1; SMN2GRM5MAPTHSD17B10
SCHEMBL27633082 0.79 KMT2A (0.51) SMN1; SMN2MAPTTSHRHSD17B10L3MBTL1
SCHEMBL20599489 0.79 MAPT (0.47) PARP10SMN1; SMN2SLC6A3GRM5MAPT
SCHEMBL1245960 0.79 OPRM1 (0.71) NNMTPARP10OPRM1OPRK1OPRD1
SCHEMBL27653513 0.79 ALDH1A1 (0.65) SMN1; SMN2SLC6A3GRM5MAPTTSHR
Hydrochloric Acid SCHEMBL5010396 0.77 OPRM1 (0.69) NNMTPARP10OPRM1OPRK1OPRD1
SCHEMBL23488259 0.76 PARP10 (0.62) NNMTPARP10OPRM1OPRK1OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 NNMT 4462/4885PARP10 1135/4885OPRM1 3557/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.